Transcenta Holding Limited

Transcenta Holding Limitedverified

6628.HK

Price:

$2.2

Market Cap:

$845.45M

Transcenta Holding Limited, a clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs in the People's Republic of China and the United States. The company develops MSB2311, a humanized PD-L1 monoclonal antibody (mAb) candidate for TMB-H solid tumors; TST001, a humanized claudin 18.2 mAb candidate for solid tumors, such as gastric cancer and is under Phase II clinical trial; TST005, a PD-L1/TGF-ß bi-functional antibody candidate which is under Phase Ia clinical trial for solid tumors, including certain lung cancers; TST010, an antibody candidate targeting regulatory T cells to enhance T cell mediated tumor ...[Read more]

Industry

Biotechnology

IPO Date

2021-09-29

Stock Exchange

HKSE

Ticker

6628.HK

The Enterprise Value as of December 2025 (TTM) for Transcenta Holding Limited (6628.HK) is 1.01B

According to Transcenta Holding Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 1.01B. This represents a change of 79.17% compared to the average of 563.59M of the last 4 quarters.

Transcenta Holding Limited (6628.HK) Historical Enterprise Value (quarterly & annually)

How has 6628.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Transcenta Holding Limited over the last ten years is 2.01B. The current 1.01B Enterprise Value has changed 4.92% with respect to the historical average. Over the past ten years (40 quarters), 6628.HK's Enterprise Value was at its highest in in the March 2020 quarter at 5.84B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

2.01B

Median

923.83M

Minimum

320.70M

Maximum

5.07B

Transcenta Holding Limited (6628.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Transcenta Holding Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 79.94%

Maximum Annual Enterprise Value = 5.07B

Minimum Annual Increase = -87.50%

Minimum Annual Enterprise Value = 320.70M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024320.70M-73.00%
20231.19B79.94%
2022660.02M23.08%
2021536.25M-87.50%
20204.29B-15.39%

Transcenta Holding Limited (6628.HK) Average Enterprise Value

How has 6628.HK Enterprise Value performed in the past?

The current Enterprise Value of Transcenta Holding Limited (6628.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

722.78M

5-year avg

1.40B

10-year avg

2.01B

Transcenta Holding Limited (6628.HK) Enterprise Value vs. Peers

How is 6628.HK’s Enterprise Value compared to its peers?

Transcenta Holding Limited’s Enterprise Value is greater than Brii Biosciences Limited (-495752424.28), greater than Sunho Biologics, Inc. (846.85M), less than Wuhan YZY Biopharma Co Ltd (1.23B), less than 3D Medicines Inc. (1.19B), greater than Sirnaomics Ltd. (111.01M), greater than JW (Cayman) Therapeutics Co. Ltd (743.94M), greater than Kintor Pharmaceutical Limited (805.77M), greater than Beijing Airdoc Technology Co., Ltd. (527.99M), less than Immunotech Biopharm Ltd (1.43B), greater than Kindstar Globalgene Technology, Inc. (834.16M),

Build a custom stock screener for Transcenta Holding Limited (6628.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Transcenta Holding Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Transcenta Holding Limited (6628.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Transcenta Holding Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Transcenta Holding Limited's Enterprise Value?

What is the highest Enterprise Value for Transcenta Holding Limited (6628.HK)?

What is the 3-year average Enterprise Value for Transcenta Holding Limited (6628.HK)?

What is the 5-year average Enterprise Value for Transcenta Holding Limited (6628.HK)?

How does the current Enterprise Value for Transcenta Holding Limited (6628.HK) compare to its historical average?